Search Results - M. V. Sedunova
- Showing 1 - 4 results of 4
-
1
Achievement of minimal disease activity in psoriatic arthritis according to the time of administration of synthetic disease-modifying antirheumatic drugs, a comparative analysis of... by T. V. Korotaeva, E. Yu. Loginova, E. E. Gubar, Yu. L. Korsakova, M. V. Sedunova, I. N. Pristavsky, I. N. Kushnir, I. F. Umnova, S. S. Kudishina
Published 2021-02-01
Article -
2
Influence of the duration of psoriatic arthritis on the achievement of remission and minimal disease activity during therapy with genetically engineered biologic drugs. Data from t... by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, M. V. Sedunova, I. N. Pristavskiy, I. N. Kushnir, I. F. Umnova, S. S. Kudishina, E. L. Nasonov
Published 2021-01-01
Article -
3
Specific features of axial involvement in psoriatic arthritis: data from real clinical practice by E. E. Gubar, E. Yu. Loginova, Yu. L. Kоrsakova, T. V. Korotayeva, S. I. Glukhova, M. V. Sedunova, I. N. Pristavsky, I. N. Bondareva, I. F. Umnova, E. L. Nasonov
Published 2020-09-01
Article -
4
OPTIMIZING THE DIAGNOSIS, A MONITORING AND TREATMENT SYSTEM FOR PSORIATIC ARTHRITIS IN REAL PRACTICE: GENERAL PRINCIPLES FOR ORGANIZING AN ALL-RUSSIAN REGISTER OF PATIENTS WITH PSO... by T. V. Korotaeva, Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, A. D. Koltakova, E. E. Medved, S. S. Kudishina, A. V. Petrov, M. V. Sedunova, I. N. Pristavsky, E. A. Vasilenko, I. N. Bondareva, I. F. Umnova, P. A. Shesternya, E. L. Nasonov
Published 2019-09-01
Article